These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34724598)

  • 41. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Jul; 24(7):973. PubMed ID: 34241968
    [No Abstract]   [Full Text] [Related]  

  • 42. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Aug; 24(8):1097. PubMed ID: 34350722
    [No Abstract]   [Full Text] [Related]  

  • 43. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance Registry.
    Int J Rheum Dis; 2020 Sep; 23(9):1262. PubMed ID: 33460304
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rheumatology update 2020: the focus was on Covid-19].
    Hügle T
    Rev Med Suisse; 2021 Jan; 17(723):214-218. PubMed ID: 33507664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How COVID-19 is changing rheumatology clinical practice.
    Bonfá E; Gossec L; Isenberg DA; Li Z; Raychaudhuri S
    Nat Rev Rheumatol; 2021 Jan; 17(1):11-15. PubMed ID: 33139947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 47. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].
    Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
    Z Rheumatol; 2021 Aug; 80(6):570-587. PubMed ID: 34309739
    [No Abstract]   [Full Text] [Related]  

  • 48. Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Østergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Nørgaard Agerbo J; Ziegler C; Lund Hetland M
    RMD Open; 2021 May; 7(2):. PubMed ID: 33941664
    [No Abstract]   [Full Text] [Related]  

  • 49. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Arnaud L; Devilliers H
    Ann Rheum Dis; 2023 May; 82(5):e113. PubMed ID: 33602796
    [No Abstract]   [Full Text] [Related]  

  • 50. Telerheumatology and its interplay with patient-initiated care.
    Mago A; Aggarwal V; Gupta L
    Rheumatol Int; 2021 Oct; 41(10):1883-1884. PubMed ID: 34165605
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Rosenbaum JT; Weisman MH; Shafer C; Aslanyan E; Howard RA; Ogle K; Hamilton H; Reveille JD; Winthrop KL; Choi D
    Ann Rheum Dis; 2023 Jun; 82(6):e138. PubMed ID: 33985940
    [No Abstract]   [Full Text] [Related]  

  • 53. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC
    Ann Rheum Dis; 2022 Oct; 81(10):e191. PubMed ID: 32796043
    [No Abstract]   [Full Text] [Related]  

  • 54. The impact of COVID-19 on rheumatology practice across Africa.
    Akintayo RO; Akpabio AA; Kalla AA; Dey D; Migowa AN; Olaosebikan H; Bahiri R; El Miedany Y; Hadef D; Hamdi W; Oyoo O; Slimani S; Yerima A; Taha Y; Adebajo AO; Adelowo OO; Tikly M; Ghozlani I; Ben Abdelghani K; Fouad NA; Mosad D; El Mikkawy D; Abu-Zaid MH; Abdel-Magied RA
    Rheumatology (Oxford); 2021 Jan; 60(1):392-398. PubMed ID: 33020845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn
    Schäfer M; Strangfeld A; Hyrich KL; Carmona L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Gossec L; Robinson PC; Yazdany J; Machado PM
    Ann Rheum Dis; 2023 May; 82(5):e116. PubMed ID: 33648957
    [No Abstract]   [Full Text] [Related]  

  • 56. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers.
    Machado PM; Schäfer M; Strangfeld A; Gossec L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Carmona L; Hyrich KL; Robinson PC; Yazdany J
    Ann Rheum Dis; 2023 May; 82(5):e114. PubMed ID: 33602795
    [No Abstract]   [Full Text] [Related]  

  • 57. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Hyrich KL; Gianfrancesco M; Machado PM; Yazdany J; Robinson PC
    Ann Rheum Dis; 2022 Nov; 81(11):e223. PubMed ID: 32895239
    [No Abstract]   [Full Text] [Related]  

  • 58. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply.
    Mikuls TR; Fraenkel L; Gravallese E; Johnson SR; Turner A; Saag KG
    Arthritis Rheumatol; 2021 Mar; 73(3):548-549. PubMed ID: 33142024
    [No Abstract]   [Full Text] [Related]  

  • 60. [CME Rheumatology 23: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].
    Tamborrini G; Micheroli R
    Praxis (Bern 1994); 2021 Apr; 110(6):293-297. PubMed ID: 33906448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.